Specific dual effect of cycloheximide on B lymphocyte apoptosis: Involvement of CPP32/caspase-3

Biochemical Pharmacology

Volumn 58, Issue 1, 1999, Pages 85-93

  Lemaire, Christophe ^a   Andréau, Karine ^a   Souvannavong, Vongthip ^a   Adam, Arlette ^a  

^a UNIVERSITÉ PARIS SACLAY   (France)

Author keywords

Apoptosis; B lymphocytes; Caspase; Cycloheximide; Dexamethasone; IL 4

Indexed keywords

BUCLADESINE; CASPASE 3; CYCLOHEXIMIDE; DACTINOMYCIN; DEXAMETHASONE; ETHIDIUM; INTERLEUKIN 4; PROTEIN SYNTHESIS INHIBITOR;

ANIMAL CELL; APOPTOSIS; ARTICLE; B LYMPHOCYTE; CELL CYCLE; CELL PROTECTION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; ENZYME ACTIVITY; FEMALE; FLOW CYTOMETRY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN SYNTHESIS; THYMOCYTE;

ANIMALS; APOPTOSIS; B-LYMPHOCYTES; CASPASE 3; CASPASES; CELL DIVISION; CYCLOHEXIMIDE; ENZYME ACTIVATION; FEMALE; MICE; MICE, INBRED C57BL; PEPTIDE BIOSYNTHESIS; PROTEIN SYNTHESIS INHIBITORS;

EID: 0033168170     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-2952(99)00082-9     Document Type: Article

References (53)

1. Golstein P., Ojcius D.M., Young J.D.-E. Cell death mechanisms and the immune system. Immunol Rev. 121:1991;29-65.
2. Cohen J.J., Duke R.C., Fadok V.A., Sellins K.S. Apoptosis and programmed cell death in immunity. Annu Rev Immunol. 10:1992;267-293.
3. Green D.R., Scott D.W. Activation-induced apoptosis in lymphocytes. Curr Opin Immunol. 6:1994;476-487.
4. Osborne B.A. Apoptosis and the maintenance of homeostasis in the immune system. Curr Opin Immunol. 8:1996;245-254.
5. Wyllie A.H., Kerr J.F.R., Currie A.R. Cell death The significance of apoptosis . Int Rev Cytol. 68:1980;251-306.
6. Schwartz L.M., Osborne B.A. Programmed cell death, apoptosis and killer genes. Immunol Today. 14:1993;582-590.
7. Vaux D.L., Strasser A. The molecular biology of apoptosis. Proc Natl Acad Sci USA. 93:1996;2239-2244.
8. Baixeras E., Bosca L., Stauber C., Gonzalez A., Carrera A.C., Gonzalo J.A., Martinez A.C. From apoptosis to autoimmunity Insights from the signaling pathways leading to proliferation or to programmed cell death . Immunol Rev. 142:1994;53-91.
9. Illera V.A., Perandones C.E., Stunz L.L., Mower D.A. Jr, Ashman R.F. Apoptosis in splenic B lymphocytes. J Immunol. 151:1993;2965-2973.
10. Wyllie A.H., Morris R.G., Smith A.L., Dunlop D. Chromatin cleavage in apoptosis Association with condensed chromatin morphology and dependence on macromolecular synthesis . J Pathol. 142:1984;67-77.
11. Ucker D.S., Ashwell J.D., Nickas G. Activation-driven T cell death. I. Requirement for de novo transcription and translation and association with genome fragmentation. J Immunol. 143:1989;3461-3469.
12. Oppenheim R.W., Prevette D., Tytell M., Homma S. Naturally occurring and induced neuronal death in the chick embryo in vivo requires protein and RNA synthesis Evidence for the role of cell death genes . Dev Biol. 138:1990;104-113.
13. Whyte M.K.B., Meagher L.C., Lee A., Haslett C. Cycloheximide and actinomycin D promote programmed cell death (apoptosis) in the neutrophil. Clin Sci. 80:(Suppl):1991;1-5.
14. Ning Z.Q., Norton J.D., Johnson D., Murphy J.J. Early gene signaling-dependent and -independent induction of apoptosis in Ramos human B cells can be inhibited by over-expression of BCL-2. Biochem Biophys Res Commun. 215:1995;23-29.
15. Edwards D.R., Mahadevan L.C. Protein synthesis inhibitors differentially superinduce c-fos and c-jun by three distinct mechanisms Lack of evidence for labile repressors . EMBO J. 11:1992;2415-2424.
16. Newton R., Adcock I.M., Barnes P.J. Superinduction of NF-κB by actinomycin D and cycloheximide in epithelial cells. Biochem Biophys Res Commun. 218:1996;518-523.
17. Martin S.J. Apoptosis Suicide, execution or murder? Trends Cell Biol. 3:1993;141-144.
18. Mattson M.P., Furukawa K. Anti-apoptotic actions of cycloheximide Blockade of programmed cell death or induction of programmed cell life? Apoptosis. 2:1997;257-264.
19. Weil M., Jacobson M.D., Coles H.S.R., Davies T.J., Gardner R.L., Raff K.D., Raff M.C. Constitutive expression of the machinery for programmed cell death. J Cell Biol. 133:1996;1053-1059.
20. Henkart P.A. ICE family proteases Mediators of all apoptotic cell death? Immunity. 4:1996;195-201.
21. Alnemri E.S. Mammalian cell death proteases A family of highly conserved aspartate-specific cysteine proteases . J Cell Biochem. 64:1997;33-42.
22. Cohen G.M. Caspases The executioners of apoptosis . Biochem J. 326:1997;1-16.
23. Nicholson D.W., All A., Thornberry N.A., Vaillancourt J.P., Ding C.K., Gallant M., Gareau Y., Griffin P.R., Labelle M., Lazebnik Y.A., Munday N.A., Raju S.M., Smulson M.E., Yamin T., Yu V.L., Miller D.K. Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosis. Nature. 376:1995;37-43.
24. Alam A., Braun M.Y., Hartgers F., Lesage S., Cohen L., Hugo P., Denis F., Sekaly R.P. Specific activation of the cysteine protease CPP32 during the negative selection of T cells in the thymus. J Exp Med. 186:1997;1503-1512.
25. Enari M., Talanian R.V., Wong W.W., Nagata S. Sequential activation of ICE-like and CPP32-like proteases during Fas-mediated apoptosis. Nature. 380:1996;723-726.
26. Ohta T., Kinoshita T., Naito M., Nozaki T., Masutani M., Tsuruo T., Miyajima A. Requirement of the caspase-3/CPP32 protease cascade for apoptotic death following cytokine deprivation in hematopoietic cells. J Biol Chem. 272:1997;23111-23116.
27. Jacobson M.D., Weil M., Raff M.C. Role of CED3/ICE-family proteases in staurosporine-induced programmed cell death. J Cell Biol. 133:1996;1041-1051.
28. Slee E.A., Zhu H.J., Chow S.C., Macfarlane M., Nicholson D.W., Cohen G.M. Benzyloxycarbonyl-Val-Ala-Asp (OMe) fluoromethylketone (Z-VAD.FMK) inhibits apoptosis by blocking the processing of CPP32. Biochem J. 315:1996;21-24.
29. Souvannavong V., Lemaire C., Denay D., Brown S., Adam A. Expression of alkaline phosphatase by a B-cell hybridoma and its modulation during cell growth and apoptosis. Immunol Lett. 47:1995;163-170.
30. Souvannavong V., Lemaire C., Andréau K., Adam A. Age-associated modulation of apoptosis and activation in murine B lymphocytes. Mech Ageing Dev. 130:1998;285-299.
31. Lemaire C., Andréau K., Souvannavong V., Adam A. Inhibition of caspase activity induces a switch from apoptosis to necrosis. FEBS Lett. 425:1998;266-270.
32. Parry S.L., Hasbold J., Holman M.J., Klaus G.G.B. Hypercross-linking surface IgM or IgD receptors on mature B cells induces apoptosis that is reversed by costimulation with IL-4 and anti-CD40. J Immunol. 152:1994;2821-2829.
33. Foote L.C., Howard R.G., Marshakrothstein A., Rothstein T.L. IL-4 induces Fas resistance in B cells. J Immunol. 157:1996;2749-2753.
34. Wechslerreya R.J., Monroe J.G. Lipopolysaccharide prevents apoptosis and induces responsiveness to antigen receptor cross-linking in immature B cells. Immunology. 89:1996;356-362.
35. Norvell A., Mandik L., Monroe J.G. Engagement of the antigen-receptor on immature murine B lymphocytes results in death by apoptosis. J Immunol. 154:1995;4404-4413.
36. Lewis J.G., Adams D.O., Fan S. Selective sensitivity of macrophages to cytotoxicity by inhibitors of macromolecular synthesis Induction of apoptosis . J Leukocyte Biol. 57:1995;635-642.
37. Scott D.W., Grdina T., Shi Y.F. T cells commit suicide, but B cells are murdered! J Immunol. 156:1996;2352-2356.
38. Andreau K., Lemaire C., Souvannavong V., Adam A. Induction of apoptosis by dexamethasone in the B cell lineage. Immunopharmacology. 40:1998;67-76.
39. Defrance T., Vanbervliet B., Aubry J.P., Banchereau J. Interleukin-4 inhibits the proliferation but not the differentiation of activated human B cells in response to interleukin-2. J Exp Med. 168:1988;1321-1337.
40. Pandrau D., Saeland S., Duvert V., Durand I., Manel A.M., Zabot M.T., Philippe N., Banchereau J. Interleukin-4 inhibits in vitro proliferation of leukemic and normal human B cell precursors. J Clin Invest. 90:1992;1697-1706.
41. Ashman R.F., Peckham D., Stunz L.L. Fc receptor off-signal in the B cell involves apoptosis. J Immunol. 157:1996;5-11.
42. Frankfurt O.S., Seckinger D., Sugarbaker E.V. Apoptosis and growth inhibition in sensitive and resistant leukemic cells treated with anticancer drugs. Int J Oncol. 4:1994;481-489.
43. Vaux D.L., Strasser A. The molecular biology of apoptosis. Proc Natl Acad Sci USA. 93:1996;2239-2244.
44. Martins L.M., Earnshaw W.C. Apoptosis Alive and kicking in 1997 . Trends Cell Biol. 7:1997;111-114.
45. An S.K., Knox K.A. Ligation of CD40 rescues Ramos-Burkitt lymphoma B cells from calcium ionophore- and antigen receptor-triggered apoptosis by inhibiting activation of the cysteine protease CPP32/Yama and cleavage of its substrate PARP. FEBS Lett. 386:1996;115-122.
46. Bellosillo B., Dalmau M., Colomer D., Gil J. Involvement of CED-3/ICE proteases in the apoptosis of B-chronic lymphocytic leukemia cells. Blood. 89:1997;3378-3384.
47. Hallan E., Blomhoff H.K., Smeland E.B., Lomo J. Involvement of ICE (caspase) family in gamma-radiation-induced apoptosis of normal B lymphocytes. Scand J Immunol. 46:1997;601-608.
48. Medina V., Edmonds B., Young G.P., James R., Appleton S., Zalewski P.D. Induction of caspase-3 protease activity and apoptosis by butyrate and trichostatin A (inhibitors of histone deacetylase) Dependence on protein synthesis and synergy with a mitochiondrial/cytochrome c-dependent pathway . Cancer Res. 57:1997;3697-3707.
49. Armstrong R.C., Aja T.J., Hoang K.D., Gaur S., Bai X., Alnemri E.S., Litwack G., Karanewsky D.S., Fritz L.C., Tomaselli K.J. Activation of the CED3/ICE-related protease CPP32 in cerebellar granule neurons undergoing apoptosis but not necrosis. J Neurosci. 17:1997;553-562.
50. Lu Q., Mellgren R.L. Calpain inhibitors and serine protease inhibitors can produce apoptosis in HL-60 cells. Arch Biochem Biophys. 334:1996;175-181.
51. Cohen G.M. Caspases The executioners of apoptosis . Biochem J. 326:1997;1-16.
52. Nicholson D.W., Thornberry N.A. Caspases Killer proteases . Trends Biochem Sci. 22:1997;299-306.
53. Mignotte B., Vayssiere J.L. Mitochondria and apoptosis. Eur J Biochem. 252:1998;1-15.